Kinnate Biopharma Inc
(KNTE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -38,902 | -17,457 | -35,761 | -22,054 | -11,555 |
| Depreciation Amortization | 879 | 307 | 88 | 59 | 36 |
| Accounts receivable | N/A | N/A | 973 | 1,127 | 973 |
| Other Working Capital | 511 | 857 | 3,014 | 4,338 | 2,598 |
| Other Operating Activity | 6,611 | 2,851 | 1,505 | 125 | -435 |
| Operating Cash Flow | $-30,901 | $-13,442 | $-30,181 | $-16,405 | $-8,383 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -201,640 | -169,627 | -31,412 | N/A | N/A |
| PPE Investments | -35 | -4 | -297 | -359 | -133 |
| Investing Cash Flow | $-201,675 | $-169,631 | $-31,709 | $-359 | $-133 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 634 | N/A | 253,209 | -49 | 21 |
| Other Financing Activity | 34,853 | 0 | 97,690 | 97,219 | -16 |
| Financing Cash Flow | $35,487 | $N/A | $350,899 | $97,170 | $5 |
| Beginning Cash Position | 365,462 | 365,462 | 76,453 | 76,453 | 76,453 |
| End Cash Position | 168,373 | 182,389 | 365,462 | 156,859 | 67,942 |
| Net Cash Flow | $-197,089 | $-183,073 | $289,009 | $80,406 | $-8,511 |
| Free Cash Flow | |||||
| Operating Cash Flow | -30,901 | -13,442 | -30,181 | -16,405 | -8,383 |
| Capital Expenditure | -35 | -4 | -297 | -359 | -133 |
| Free Cash Flow | -30,936 | -13,446 | -30,478 | -16,764 | -8,516 |